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Mind the gap: connexins and pannexins in platelet function
Kirk a Taylor 1,2*, Gemma Little 1, & Jonathan M. Gibbins 1
1Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK and 2National Heart and Lung Institute, Imperial College 
London, London, UK
Abstract
Connexins are a family of gap junction forming proteins widely expressed by mammalian cells. 
They assemble into hexameric hemichannels, which can either function independently or dock 
with opposing hemichannels on apposite cells, forming a gap junction. Pannexins are structu-
rally related to the connexins but extensive glycosylation of these channels prevents docking 
to form gap junctions and they function as membrane channels. Platelets express pannexin-1 
and several connexin family members (Cx37, Cx40 and Cx62). These channels are permeable to 
molecules up to 1,000 Daltons in molecular mass and functional studies demonstrate their role 
in non-vesicular ATP release. Channel activation is regulated by (patho)physiological stimuli, 
such as mechanical stimulation, making them attractive potential drug targets for the manage-
ment of arterial thrombosis. This review explores the structure and function of platelet 
pannexin-1 and connexins, the mechanisms by which they are gated and their therapeutic 
potential.
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Introduction
Platelets circulate in a complex environment, interacting with 
other blood cells and the vessel wall. Vascular injury or rupture 
of atherosclerotic plaques expose thrombogenic molecules (e.g., 
vWF and collagen) that initiate platelet recruitment, activation 
and thrombus formation, resulting in hemostasis or thrombosis, 
respectively. The platelet response to injury is rapid and propor-
tionate, orchestrated by complex interplay of activatory and inhi-
bitory signals [1]. Conversely, arterial thrombosis arises from 
pathological platelet activation and leads to myocardial infarction 
and stroke. The discovery of platelet connexin (Cx) gap junction 
proteins and a structurally related pannexin-1 (Panx1) channel on 
platelets may provide previously unrecognized mechanisms for 
communication between platelets to regulate the thrombotic 
response. This review explores recent developments in the struc-
ture and function of platelet connexins and Panx1, the potential 
roles that these proteins may play in platelet-related diseases and 
their prospects as antiplatelet targets.
Structure and Function of Connexins and Pannexins
Connexins have been studied widely and members of this family 
of 21 proteins [2] play critical roles in regulating signal transduc-
tion and propagating calcium waves in a range of tissues. 
Connexin gap junctions ensure coordinated responses by 
neighboring cells (reviewed in [3]) since connexin mediated inter-
cellular signaling is limited only by the rate of diffusion of signal 
molecules conveyed by these channels. Connexins form a broad 
family of proteins and are denoted by their molecular mass (i.e., 
Cx32 displays an apparent molecular mass of 32 kDa when 
analyzed by SDS-PAGE). Connexin monomers assemble into 
hexameric hemichannels and are trafficked to the plasma mem-
brane where docking of two hemichannels on apposite cells forms 
a gap junction, allowing intercellular flow of molecules up to 
1000 Daltons in size. Connexin hemichannels may be formed by 
a single member of the connexin family (homomeric) or from 
a mixture of family members (heteromeric) [4]. Docking of 
homomeric or heteromeric hemichannels, gives rise to assembly 
of homotypic and heterotypic gap junctions, respectively 
(Summarized in Figure 1). Intermixing of connexins in this way 
has been shown to influence the nature of intercellular signal 
transduction; for example, Cx26:Cx37 heterotypic gap junctions 
have enhanced permeability to cGMP over cAMP, compared with 
Cx37 homotypic junctions [4]. The functional significance of 
potential connexin intermixing in platelets is not understood, 
although it is interesting to note the substantial and similar impact 
of the inhibition or deletion of each of Cx37, 40 and 62, which 
may suggest that platelet connexins may collaborate in these cells 
[5–7]. Connexins also function as hemichannels at the plasma 
membrane, providing a route for release of cytosolic signaling 
molecules, such as ATP [8]. Hemichannel and gap junction mod-
alities may provide distinct roles for connexins in freely circulat-
ing platelets and within thrombi, respectively.
Pannexins were first reported in 2000 by Panchina and collea-
gues, during a genetic screen for invertebrate gap junction homo-
logues [9]. This family of three proteins displays distinct 
expression patterns whereby Panx1 is ubiquitously expressed, 
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pannexin-2 is restricted to the brain and central nervous system 
and pannexin-3 is predominantly found in bone and skin cells 
[10]. Early studies of Panx1 suggested that these proteins assem-
ble into hexameric channels before becoming glycosylated and 
trafficked to the plasma membrane [11]. However, this classical 
view of hexameric channels has been challenged by two 
independent cryo-EM studies of the Panx1 structure, which report 
that seven Panx1 monomers assemble to form heptameric chan-
nels [12,13]. These channels diverge further from connexins as 
glycosylation of the second extracellular loop at N254 prevents 
docking of apposite Panx1 channels [14]. This was tested by two- 
electrode voltage clamp measurements of Xenopus laevis oocytes 
expressing Panx1. When the glycosidase PNGaseF was applied to 
the bath solution, N-linked glycans on Panx1 were broken down 
and a junctional conductance could be recorded [11]. Under 
physiological conditions Panx1 does not form gap junctions[15], 
rather, these proteins form anion-selective ion channels at the 
plasma membrane (Figure 1) [16].
Expression and Localization of Platelet Pannexin-1 and 
Connexins
Platelet proteomic and transcriptomic analyses report expression of 
Panx1 and significant levels of Cx32, Cx37, Cx40 and Cx62 [17–-
17–20]. Panx1 is the sole pannexin expressed by platelets and 
qPCR analysis of platelet mRNA demonstrated that Panx1 may 
be expressed at similar levels to the ATP-gated ion channel P2X1 
[21]. Protein expression, biotinylation and biochemical studies 
suggest that platelet Panx1 is glycosylated and the majority of 
these channels are expressed at the plasma membrane, where they 
become activated downstream of agonist-evoked platelet activation 
[21]. Molica and colleagues reported a functional defect in subjects 
that have a single nucleotide polymorphism of C400A, leading to 
reduced collagen-evoked platelet aggregation responses [22].
Of the 16 connexins screened from blood cells and megakar-
yocytes, notable levels of Cx37, Cx40 and Cx62 mRNA were 
detected from cultured megakaryocytes [18]. Expression of Cx37 
and Cx40 has been confirmed by Western blotting, immunocyto-
chemistry and flow cytometry [5,6,18]. More recently, Cx62 was 
identified in human platelets, where it was shown to reside 
intracellularly before translocating to the plasma membrane 
upon stimulation by the thromboxane A2 mimetic U46619 [7]. 
People carrying a single nucleotide polymorphism P319S in the 
Cx37 gene display modestly enhanced platelet activation, suggest-
ing a role for Cx37 in regulating platelet activation [5]. To date, 
platelet connexins have been shown to function both as hemi-
channels and gap junctions [5–7,18]. Of the platelet connexins, 
evidence suggests that whilst Cx37 and Cx40 cannot form hetero-
meric structures, they are able to assemble in a heterotypic man-
ner between apposite cells [23]. Clot retraction is a coordinated 
process whereby microtubules contract to facilitate wound healing 
[24]. Interestingly, selective peptide inhibitors of either Cx37, 
Cx40 or Cx62 inhibit clot retraction, suggesting that there may 
be a role for gap junctions in the coordination of this process 
[6,7,18]. Connexin intermixing has not been studied in platelets 
but this could serve to regulate platelet interactions within 
a thrombus or with other cell types.
Functional roles for Panx1 and platelet connexins have been 
demonstrated in vitro and in vivo. Conflicting reports indicate that 
global knockout of Cx37 reduces bleeding time [5], whilst admin-
istration of a Cx37 blocking peptide decreases thrombus forma-
tion in vivo [18]. The underlying differences between these 
reports remain unclear and further studies with platelet-specific 
deletion of Cx37 are required. Furthermore, Cx40−/- mice have 
increased tail bleeding times, suggesting a regulatory role for this 
connexin during platelet activation [6]. Cx62 has been shown to 
contribute to thrombus formation in vivo as thrombi were signifi-
cantly smaller in mice treated with a selective inhibitory peptide 
[7]. A common platelet phenotype was observed with each con-
nexin knockout mouse whereby fibrinogen binding, P-selectin 
exposure and ATP release were all reduced [6,7]. In vivo studies 
demonstrate that Panx1 contributes to both hemostasis and 
Figure 1. Expression and assembly of platelet connexins and pan-
nexin-1. (a) Platelets express Cx37, Cx40 and Cx62 and pannexin-1 
(Panx1). Connexins form nonselective hexameric hemichannels and pan-
nexin-1 forms heptameric anion-selective channels that are detected at the 
plasma membrane. (b) Docking of two apposite hemichannels forms 
a gap junction that facilitates intercellular communication. (c) Gap junc-
tions form between two hemichannels by either homotypic (e.g., Cx37: 
Cx37) or heterotypic (e.g., Cx37:Cx40) assembly, which may influence 
gap junction permeability. The molecular identity of platelet gap junc-
tions and whether they are homo/heterotypic has not been studied. Panx1 
cannot form gap junctions due to glycosylation on its second extracellular 
loop. Created in BioRender.
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thrombosis with significantly elevated tail bleeding times and 
reduced mortality in a thromboembolic model in Panx1−/- mice 
[25]. Extensive evidence therefore supports the notion that con-
nexins, specifically Cx375[18], 406 and 627, and Panx121 [25,26], 
perform important regulatory roles in platelet function in hemos-
tasis and thrombosis.
What Messages are Conveyed by Connexins and 
Pannexins
Connexins and Panx1 contribute to platelet function in vivo and 
may represent potential antithrombotic targets. These proteins 
form large pores but the precise nature of the signals conveyed 
by platelet connexins and/or Panx1 remains unclear. Functional 
studies have tended to focus on the loss or transfer of cytosolic 
calcein, a 622 Dalton anionic fluorescent dye, in flow cytometry 
and FRAP (fluorescence recovery after photobleaching) assays 
[7,21]. These channels are also known to represent pathways for 
non-vesicular release of cytosolic ATP [27,28]. ATP release 
through Panx1 and connexin hemichannels has been demon-
strated using ATP-dependent luciferin-luciferase assays in platelet 
suspensions [6,7,18,21]. To date, transfer of other molecules, such 
as ADP, cyclic nucleotides, ions (e.g., Ca2+2, Cl−, Zn2+) and 
inositol-1,4,5-trisphosphate (IP3), has not been demonstrated in 
platelets or megakaryocytes. It is tempting to speculate that 
transfer of IP3 via gap junctions within a thrombus, akin to that 
within cardiac muscle[29], may serve to coordinate and propagate 
platelet calcium waves within a growing thrombus.
Regulation of Pannexin and Connexin Channels
Connexin and pannexin channels and junctions must be appro-
priately regulated to prevent leakage of cytosolic content (e.g., 
ATP) and influx of extracellular ions (e.g., Ca2+), which would 
disrupt various aspects of cellular homeostasis. To this end, multi-
ple regulatory mechanisms have evolved to control gating of 
pannexin and connexin channels and ultimately gap junction for-
mation. Such mechanisms include post-translational modifica-
tions (PTMs), mechanical stimulation, ischemia, channel gating 
by extracellular ions and enzymatic cleavage [27,30–35], and are 
explored herein.
Phosphorylation (Figure 2A)
Regulation of platelet connexins and Panx1 by PTMs presents 
a mechanism for the efficient switching on/off of these channels 
in response to environmental cues. In the case of Panx1, several 
putative phosphorylation sites have been reported for Src Family 
Kinases (SFKs), protein Kinase A (PKA) and Protein Kinase 
C (PKC) [31,36,37]. Collagen-evoked platelet activation leads to 
Panx1 phosphorylation at Y308, which is inhibited by preincuba-
tion with the SFK inhibitor PP2 [25]. The functional relevance of 
predicted PKA and PKC sites on Panx1 are not yet clear. 
Regulation of platelet Cx37 and Cx40 by phosphorylation is 
unknown, although UniProt annotations suggest that these chan-
nels have several predicted serine, threonine and tyrosine phos-
phorylation sites. Related Cx43 channels are broadly expressed 
and deletion of this gene is embryonic lethal [35]. A detailed 
review of Cx43 phosphorylation [38] highlights 19 conserved 
kinase recognition motifs in the C terminus, and discusses how 
Figure 2. Proposed mechanisms for regulation of platelet connexins and pannexin-1. (a) Phosphorylation- Pannexin-1 (Panx1) is phosphorylated by Src 
Family Kinases (SFKs) at Y308, leading to channel opening. Platelet connexins have predicted phosphorylation protein kinase C (PKC) sites and Cx62 may 
interact with protein kinase A (PKA). (b) Gating by Ca+- Connexin hemichannels are open in the absence of extracellular Ca2+ ([Ca2+o) and close when [Ca2+]o 
rises to 2–4 mM. Panx1 channels open in response to a rise of intracellular Ca2+ ([Ca2+]i) that leads to ATP release and stimulation of P2X1 on platelets. (c) 
Enzymatic cleavage- The intracellular C-terminus of Panx1 contains a zymogen site that is cleaved by caspase-3, removing an auto inhibitory domain, facilitating 
channel activation and ATP release. (d) Mechanical stimulation- Mechanical deformation and elevated shear stress have been shown to stimulate Panx1 channels. 
Studies of cardiac muscle report increased expression of Cx43 following sustained exposure to shear stress. (e) Protein trafficking- Connexins are expressed at the 
plasma membrane for relatively short periods (half-life (T1/2) = 1.5–3 hours) and are trafficked and recycling in response to cellular activation. Panx1 is stably 
expressed at the plasma membrane with a T1/2 of approximately 24 hours. Created in BioRender.
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changes in Cx43 phosphorylation lead to alteration of hemichan-
nel and gap junction permeability and electrophysiological prop-
erties. Cx37 has been shown to be negatively regulated by PKC in 
rat insulinoma cells, where PKC inhibition increased the open 
state probability [30]. A potential link between Cx62 and PKA 
was recently reported; platelets incubated with a selective Cx62 
inhibitory peptide had increased levels of PKA-mediated VASP 
phosphorylation, which occurs in a cAMP-independent manner 
[7]. It is currently unclear whether this implicates PKA in the 
phosphorylation and regulation of Cx62 function, or that Cx62 is 
able to induce inhibitory signaling pathways that involve PKA. 
Further studies are required to fully understand the functional 
significance of phosphorylation-mediated regulation of platelet 
connexins and Panx1.
Gating by Ca2+ (Figure 2B)
Gating of connexin hemichannels by extracellular ([Ca2+]0) was 
demonstrated by atomic force microscopy studies in HeLa cells 
expressing recombinant Cx40. In this study hemichannels were 
open in Ca+ free conditions but closed when [Ca2+]0 was elevated 
to 3.6 mM [39]. Molecular dynamic simulations based on Cx26 
suggest that a [Ca+]0 sensing motif within the hemichannel pore is 
responsible for channel closure and this motif is conserved between 
connexin family members [32]. Whilst, these studies suggest that 
physiological levels of [Ca2+] markedly reduce the open probabil-
ity of connexin hemichannels, it is not clear whether this phenom-
enon can be overcome by other regulatory mechanisms, such as 
phosphorylation or mechanical stimulation. Given that connexins 
contribute to platelet activation in flow cytometric studies with 
physiological levels of [Ca2+]0 [5–7,18], where hemichannels are 
predicted to be closed, it is possible that this inhibition could be 
overcome by direct stimulation of the connexin by phosphorylation 
or mechanical forces. Panx1 channels do not appear to be directly 
affected by fluctuations of [Ca2+]o [40], rather elevation of intra-
cellular Ca+ ([Ca2+]o) leads to the activation of Panx1, via an 
unknown mechanism [41]. Activation of platelet Panx1 was pro-
posed to be mediated by collagen-evoked [Ca2+]o+ calcium signal-
ing, leading to ATP release and amplification of the aggregation 
response [21]. Further studies are required to unravel the mechan-
isms that govern Ca+-mediated gating of platelet Pannexin and 
Connexin channels.
Enzymatic Cleavage (Figure 2C)
Structural studies of Panx1 indicate that the cytoplasmic 
C-terminus becomes inserted into the pore region, serving as an 
autoinhibitory mechanism. Furthermore, this region has 
a zymogen site that is cleaved by caspase 3. Cleavage of the 
C-terminus leads to a terminal open state that is thought to release 
ATP as an apoptotic “find-me” signal [33,42]. These findings 
suggest that Panx1 may exist in multiple open states to respond 
to different stimuli. Indeed, direct stimulation of Panx1 by extra-
cellular K+ led to channel activation with conductance of 500ps, 
whereas voltage-dependent activation of the channel led to 
a lower 50ps conductance that was not associated with ATP 
release [43]. Such regulation may enable Panx1 to release differ-
ent cargos in response to different stimuli.
Mechanical Stimulation (Figure 2D)
Platelets and megakaryocytes express stretch-activated Piezo 1 
[44], TRPM7 [45,46] and TRPV4 [47] cation channels. This 
could ultimately prove to be an important mechanism for shear- 
dependent platelet activation in the context of stenosed vessels with 
pathological shear rates. Intercellular transmission of Ca[2]+ 
signals has been reported during in vitro adhesion assays and dis-
plays an ADP-dependent component [48]. The pathway for this 
ADP release is unclear and may be mediated by dense granule 
release, Panx1 channels or connexin hemichannels. Notably, ery-
throcyte Panx1 channels were shown to release ATP in response to 
mechanical deformation [27]. Furthermore, sustained exposure to 
shear stress increased endothelial Cx40 expression [49]. Platelet 
adhesion to collagen under arteriolar shear rates (1000s−1) has 
been shown to be sensitive to connexin and Panx1 inhibitors 
[6,18,21].
Protein Trafficking (Figure 2E)
Protein trafficking represents an alternative mechanism for the 
regulation of pannexins and connexins. The half-life of connexin 
hemichannels at the plasma membrane is estimated to be between 
1.5 and 5 h [50]. By comparison, heterologously expressed rat 
Panx1 channels in human embryonic kidney cells are stably 
expressed at the plasma membrane, with 45% of channels remain-
ing after 24 h [11]. D-STORM imaging of platelet Cx62 demon-
strated that these channels are increasingly associated with the 
plasma membrane following stimulation [7]. Further studies are 
required to evaluate the role of trafficking in the dynamic regula-
tion of connexins in response to (patho)physiological stimuli.
Therapeutic Potential
Connexins and Panx1 have been studied using the inhibitors carbe-
noxolone, probenecid, and spironolactone, which are also FDA- 
approved drugs for the management of tracheal ulcers, gouty arthritis 
and hypertension, respectively [18,21,27,51]. This raises the question 
as to whether these drugs could be repurposed to manage arterial 
thrombosis. One potential limitation to such an approach would be 
off-target effects upon other connexin family members or through 
inhibition of Panx1 on other cell types. For example, inhibitors of 
Cx40 in the circulation would not only target platelet function but also 
endothelial and cardiac cells that also express Cx40. It is worth noting, 
however, that Cx37−/- mice do not have a cardiovascular phenotype 
and Cx40−/- mice have reduced cardiac conduction velocity, leading to 
increased incidence of arrhythmias, suggesting that there may be some 
functional redundancy between family members [52–54]. 
Furthermore, it is worth considering that these drugs target other 
receptors, introducing the potential for undesired effects. However, 
these drugs have been in clinical use for several decades and therefore 
have established safety profiles. Interestingly, orally administered 
probenecid achieves plasma concentrations of ≈78 µM, which is 
sufficient to achieve inhibition of platelet Panx1 channels [21]. 
Probenecid has also been shown to enhance the effects of indometha-
cin and heparin, without increasing the plasma half-life of these drugs 
[55,56]. Pharmaco-epidemiological approaches could be employed to 
assess the relationship between administration of known gap junction 
or pannexin blockers on the incidence of cardiovascular diseases. 
However, this would require careful consideration of confounding 
factors as people diagnosed with gouty arthritis or hypertension may 
be predisposed to thrombotic diseases.
An alternative approach would be to develop small molecule 
inhibitors that target specific connexin or pannexin isoforms. 
Isotype specific inhibitory peptides that target the extracellular 
loops of connexins [7,57] and Panx1[58] have been employed 
successfully to study the function of these proteins in vitro and 
in vivo. These target sequences could therefore be used to inform 
the development of small molecule inhibitors to target these 
proteins on platelets and manage thrombosis.
Ex vivo analyses demonstrated that mouse platelets treated 
with probenecid, reduced murine platelet aggregation [25,51]. In 
vitro thrombus formation assays also demonstrate reduced 
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thrombus formation in the presence of carbenoxolone or probe-
necid [18,21]. Furthermore, potential roles for platelet gap junc-
tions and pannexin channels in ischemic stroke are not resolved, 
although a middle cerebral artery occlusion stroke model demon-
strated that female Panx1-deficient mice exhibited reduced neu-
rological impairment at 48 h compared with controls [59]. These 
data suggest that there may be therapeutic potential in repurpos-
ing drugs that are well-tolerated, for the cost-effective manage-
ment of thrombosis and ischemic stroke.
Future Directions and Conclusions
To date, studies have primarily focussed on the role of platelet 
connexins and pannexins, however, these proteins are also expressed 
within the megakaryocyte. Within the bone marrow, Cx43 is the 
predominant connexin isoform and is expressed by megakaryocytes 
[60]. Indeed, megakaryocytes have been shown to reduce deposition 
of type I collagen by osteoclasts, through Cx43-mediated interac-
tions [61]. The direct roles of connexins and pannexins during 
megakaryocyte development and thrombopoiesis have not been 
evaluated, but data suggest that platelet counts are normal in both 
Cx37 and panneixn-1 knockout mice [5,25].
Despite their structural and functional similarities, there is rela-
tively little data available on the interactions between the pannexins 
and connexins. Noveielli-Kuntz and colleagues evaluated the cardi-
ovascular phenotype of Cx40−/-, Panx1−/- and Cx40−/-Panx1−/- mice 
[62]. Cx40-deficient mice have impaired vasodilation of aortic seg-
ments, leading to hypertension, a phenotype not observed in 
Panx1−/- mice. This phenotype was explored further with the double 
knockout and Panx1 depletion could not rescue the vascular pheno-
type of Cx40−/- [62]. However, the impact of this model upon 
platelet function and thrombus formation was not assessed. In vivo 
thrombosis studies with Cx40−/- [6] and Panx1−/- [25] mice both 
report reduced thrombus formation, indicating therapeutic potential 
in targeting these channels.
Platelets express Panx1 and multiple members of the connexin 
gap junction family. These channels are activated following plate-
let stimulation, contributing to ATP release, Ca[2]+ signaling and 
platelet activation dynamics. Our understanding of the role for 
platelet gap junctions during thrombus formation is currently 
limited. Gap junctions may represent, however, a route for rapid 
transmission of signals between the core and shell of a growing 
thrombus. Finally, these channels have been shown to be suscep-
tible to drugs that are in clinical use, which could potentially be 
repurposed to manage arterial thrombosis.
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